| 1 | = | Malignant Breast Neoplasm | 195,637 | 100 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 1641
- siteDefinition
- USCS "Female Breast" (ICD-10 C50; ICD-O-3 C500-C509)
ranking row 2594001 |
| 2 | = | Malignant Lung Neoplasm | 91,135 | 96.4 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 3729
- siteDefinition
- USCS "Lung and Bronchus" (ICD-10 C34; ICD-O-3 C340-C349)
ranking row 2594002 |
| 3 | = | Malignant Colon Neoplasm | 57,622 | 92.9 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 825
- siteDefinition
- USCS "Colon excluding Rectum" (ICD-10 C18, C26.0; ICD-O-3 C180-C189, C260)
ranking row 2594003 |
| 4 | = | Malignant Uterine Corpus Neoplasm | 35,823 | 89.3 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 1131
- siteDefinition
- USCS "Corpus" (ICD-10 C54; ICD-O-3 C540-C549)
ranking row 2594004 |
| 5 | = | Non-Hodgkin Lymphoma | 27,102 | 85.7 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 5259
- siteDefinition
- USCS "Non-Hodgkin Lymphoma" (ICD-10 C82-C85, C96.3; ICD-O-3 histology 9590-9597, 9670-9729, 9735, 9737-9738 (+9811-9818, 9823, 9827, 9837 outside marrow/blood))
ranking row 2594005 |
| 6 | = | Malignant Ovarian Neoplasm | 21,800 | 82.1 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 5565
- siteDefinition
- USCS "Ovary" (ICD-10 C56; ICD-O-3 C569)
ranking row 2594006 |
| 7 | = | Cutaneous Melanoma | 21,614 | 78.6 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 4035
- siteDefinition
- USCS "Melanomas of the Skin" (ICD-10 C43; ICD-O-3 C440-C449 with histology 8720-8790)
ranking row 2594007 |
| 8 | = | Malignant Thyroid Gland Neoplasm | 19,748 | 75 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 6993
- siteDefinition
- USCS "Thyroid" (ICD-10 C73; ICD-O-3 C739)
ranking row 2594008 |
| 9 | = | Malignant Rectal Neoplasm | 17,851 | 71.4 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 6075
- siteDefinition
- USCS "Rectum and Rectosigmoid Junction" (ICD-10 C19-C20; ICD-O-3 C199, C209)
ranking row 2594009 |
| 10 | = | Leukemia | 17,047 | 67.9 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 3117
- siteDefinition
- USCS "Leukemias" (ICD-10 C91-C95 (leukemia recodes; C90.1 plasma cell leukemia included by SEER); ICD-O-3 leukemia histologies 9733-9948 per SEER site recode)
ranking row 2594010 |
| 11 | = | Malignant Pancreatic Neoplasm | 17,004 | 64.3 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 5769
- siteDefinition
- USCS "Pancreas" (ICD-10 C25; ICD-O-3 C250-C259)
ranking row 2594011 |
| 12 | = | Malignant Bladder Neoplasm | 16,330 | 60.7 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 7299
- siteDefinition
- USCS "Urinary Bladder" (ICD-10 C67; ICD-O-3 C670-C679)
ranking row 2594012 |
| 13 | = | Malignant Kidney Neoplasm | 16,226 | 57.1 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 2505
- siteDefinition
- USCS "Kidney and Renal Pelvis" (ICD-10 C64-C65; ICD-O-3 C649, C659)
ranking row 2594013 |
| 14 | = | Malignant Cervical Neoplasm | 12,707 | 53.6 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 621
- siteDefinition
- USCS "Cervix" (ICD-10 C53; ICD-O-3 C530-C539)
ranking row 2594014 |
| 15 | = | Malignant Central Nervous System Neoplasm | 9,083 | 50 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 315
- siteDefinition
- USCS "Brain and Other Nervous System" (ICD-10 C70, C71, C72; ICD-O-3 C700-C709, C710-C719, C720-C729)
ranking row 2594015 |
| 16 | = | Malignant Gastric Neoplasm | 8,360 | 46.4 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 6687
- siteDefinition
- USCS "Stomach" (ICD-10 C16; ICD-O-3 C160-C169)
ranking row 2594016 |
| 17 | = | Multiple Myeloma | 8,109 | 42.9 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 4647
- siteDefinition
- USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734)
ranking row 2594017 |
| 18 | = | Malignant Liver Neoplasm | 4,973 | 39.3 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 3423
- siteDefinition
- USCS "Liver and Intrahepatic Bile Duct" (ICD-10 C22; ICD-O-3 C220-C221)
ranking row 2594018 |
| 19 | = | Malignant Vulvar Neoplasm | 3,839 | 35.7 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 7809
- siteDefinition
- USCS "Vulva" (ICD-10 C51; ICD-O-3 C510-C519)
ranking row 2594019 |
| 20 | = | Hodgkin Lymphoma | 3,768 | 32.1 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 1743
- siteDefinition
- USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal))
ranking row 2594020 |
| 21 | = | Malignant Esophageal Neoplasm | 3,352 | 28.6 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 1335
- siteDefinition
- USCS "Esophagus" (ICD-10 C15; ICD-O-3 C150-C159)
ranking row 2594021 |
| 22 | = | Malignant Anal Neoplasm | 2,729 | 25 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 9
- siteDefinition
- USCS "Anus, Anal Canal and Anorectum" (ICD-10 C21; ICD-O-3 C210-C212, C218)
ranking row 2594022 |
| 23 | = | Malignant Laryngeal Neoplasm | 2,556 | 21.4 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 2811
- siteDefinition
- USCS "Larynx" (ICD-10 C32; ICD-O-3 C320-C329)
ranking row 2594023 |
| 24 | = | Malignant Salivary Gland Neoplasm | 1,450 | 17.9 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 6381
- siteDefinition
- USCS "Salivary Gland" (ICD-10 C07-C08; ICD-O-3 C079-C089)
ranking row 2594024 |
| 25 | = | Malignant Vaginal Neoplasm | 1,156 | 14.3 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 7605
- siteDefinition
- USCS "Vagina" (ICD-10 C52; ICD-O-3 C529)
ranking row 2594025 |
| 26 | = | Malignant Mesothelioma | 690 | 10.7 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 4341
- siteDefinition
- USCS "Mesothelioma" (ICD-10 C45; ICD-O-3 histology 9050-9055 (any site))
ranking row 2594026 |
| 27 | = | Malignant Nasopharyngeal Neoplasm | 539 | 7.1 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 4953
- siteDefinition
- USCS "Nasopharynx" (ICD-10 C11; ICD-O-3 C110-C119)
ranking row 2594027 |
| 28 | = | Malignant Hypopharyngeal Neoplasm | 450 | 3.6 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 2049
- siteDefinition
- USCS "Hypopharynx" (ICD-10 C12-C13; ICD-O-3 C129, C130-C139)
ranking row 2594028 |
| 29 | = | Kaposi Sarcoma | 184 | 0 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 2355
- siteDefinition
- USCS "Kaposi Sarcoma" (ICD-10 C46; ICD-O-3 histology 9140 (any site))
ranking row 2594029 |